UEEC

What one share of United Health Products holds

Orthopedic, Prosthetic and Surgical Appliances and Supplies

United Health Products, Inc. (“UHP”, “we” or the “Company”) develops, manufactures, and markets a patented hemostatic gauze for the healthcare and wound care sectors. Our gauze product, CelluSTAT®, is derived from cotton and designed to absorb exudate/drainage from superficial wounds and help control bleeding.

United Health Products’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.

Per-share figures
Sales$0.00
Profit−$0.01
Cash and investments$0.00
Debt$0.00
Book value−$0.02

Per share by fiscal year

YearSalesProfitCapexFree cashDividendsBook value
2010$0.00−$0.06———−$0.01
2017$0.00−$0.01———−$0.00
2018$0.00−$0.03———−$0.00
2019$0.00−$0.04$0.00−$0.01—−$0.01
2020$0.00−$0.09$0.00−$0.01—−$0.01
2023$0.00−$0.01———−$0.01
2024$0.00−$0.01———−$0.01
2025$0.00−$0.01———−$0.01

Common questions about United Health Products

How much does one share of United Health Products earn?

Over the last 12 months, United Health Products lost $0.01 for each share.

Does United Health Products pay a dividend?

United Health Products didn’t pay a dividend over the last 12 months, according to its SEC filings.

What is United Health Products’s book value per share?

United Health Products’s book value is negative (−$0.02 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of June 30, 2026.

How much cash and debt does each share of United Health Products have?

Each share of United Health Products has $0.00 of cash and investments and $0.00 of debt, as of June 30, 2026.

Has United Health Products bought back shares?

United Health Products’s share count rose about 432% from 2010 to 2025. That dilution means each share owns a smaller slice of the company.

From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.